
==== Front
J Med Case Rep
J Med Case Rep
Journal of Medical Case Reports
1752-1947
BioMed Central London

39237979
4752
10.1186/s13256-024-04752-4
Case Report
Spitzoid melanoma of the finger: a case report
Rekik Mohamed Ali 12
Rouabeh Amal 12
http://orcid.org/0009-0007-1592-1688
Guermazi Yahya Yahya.Guermazi20@gmail.com

12
Dahech Fedi 12
Ellouz Zoubeir 12
Keskes Hassib 12
1 grid.413497.c Orthopedic Surgery and Traymatology, Habib Bourguiba Hospital, Sfax, Tunisia
2 University of Medicine of Sfax, Sfax, Tunisia
6 9 2024
6 9 2024
2024
18 4133 6 2024
9 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Background

Melanoma is the most malignant skin tumor, with a high metastatic potential.

Spitzoid melanoma is a subtype of melanoma requiring rapid management and extensive tumor resection.

We have set the goal to recognize anatomical peculiarities and difficulties diagnoses posed by this type of tumor, as well as to recognize the management modalities, especially the surgical one, of malignant spitzoid melanoma.

Case presentation

A 25-year-old Tunisian male patient had consulted for nodular lesion of the right index, evolving for 4 years. A malignant tumor was strongly suspected, then confirmed as a melanoma by a biopsy excision.

Initially, the excision was incomplete in depth, suggesting a complementary surgery, but the patient refused it; 3 years later, the patient again consulted after the appearance of an axillary lymphadenopathy and worsening of the skin lesion. A supplement of tumor removal with lymph node biopsy were performed. It was decided to perform an amputation of the second ray and the first commissure with cheiroplasty, reconstructing a four-finger hand. An homolateral axillary cleaning was performed at the same time.

The postoperative result is considered esthetically and functionally satisfying.

The evolution was marked by the appearance of pulmonary metastases, requiring adjuvant chemotherapy.

A regression of the nodule under the mammary skin and total disappearance of axillary nodes have been marked; but the patient’s condition rapidly deteriorated, and he died after a 2-month decline.

Conclusion

Spitzoid melanoma is exceptional, posing difficulties in diagnostics, and it should not be underestimated, considering that it may involve the vital prognosis.

Knowledge of this rare form of melanoma is important to avoid misdiagnosis, which delays diagnosis and subsequent therapy.

Keywords

Skin
Tumor
Melanoma
Surgery
Reconstruction
Case report
issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcIntroduction

Malignant skin tumors are an entity requiring surgical treatment, which can be mutilating because it sometimes demands a wide-ranging excision. This treatment can even lead to an amputation of a limb or a limb segment. Melanoma is the most malignant skin tumor, which has a high metastatic potential. It originates from melanocytes, which are cells that produce melanin, the pigment responsible of the color of the skin, the eyes, and the hair. Malignant melanoma accounts for 5% of all skin cancers, and is the leading cause of death from skin cancer, with a 75% incidence rate [1]. Its incidence is constantly increasing in all populations. The high mortality associated with this condition makes early diagnosis very important. The pathological type of tumor and the depth of the invasion are determinants of overall prognosis. Digital melanoma is rare, occurring most often in the elderly, representing less than 2% of all skin melanomas [2]. Spitzoid melanoma is a subtype of melanoma, which makes its diagnosis is difficult. It looks clinically and histologically like a Spitz nevus, with high metastatic potential and a bleak prognosis, requiring fast management and wide tumor resection [3].

Through an observation of a patient operated on at the orthopedic department of Habib Bourguiba Hospital Sfax – Tunisia and a literature review, we have set the goal of:Recognizing anatomical peculiarities and difficulties diagnoses posed by this type of tumor.

Recognizing the management modalities, especially the surgical one, of malignant spitzoid melanoma.

Case presentation

A 25-year-old Tunisian male patient with no specific medical history had consulted for nodular lesion of the right index, evolving for 4 years. This lesion was papular and 5 mm in diameter, increasing gradually in size and becoming painful. Clinical examination at the admission showed a fairly well-limited nodular lesion infiltrated, firm of 2 cm long axis, with ulcerated center and hyperkeratotic area, sitting in look at the radial edge of the metacarpophalangeal joint of the right index finger (Fig. 1). A malignant tumor was strongly suspected.Fig. 1 Ulceroinvasive lesion, 1.5 cm in diameter, next to the radial edge of right index metacarpal-phalangial joint

A node biopsy excision showed a cellular proliferation made of large or fusiform epithelioid cells with little abundant cytoplasm weakly eosinophilic without melanic pigments and with atypical nucleus well nucleated and hyperchromatic; these cells were arranged in small clusters or in high-level theses at contact of the dermoepidermal junction, giving a characteristic spitzoid appearance; mitoses were quite a lot especially in depth and stroma was profuse desmoplastic (Fig. 2).Fig. 2 a Tumor proliferation widely ulcerated on the surface (hematoxylin and eosin × 100). b Tumor proliferation of oval globular cells in the dermoepidermal junction. Clear artifact spaces separating cells tumors of squamous cells (hematoxylin and eosin × 400). c Proliferation of tumor cells infiltrating the deep dermis. Note the presence of prominent nucleoli (hematoxylin and eosin × 400). d HMB45 immunopositive (× 400)

Immunohistochemical examination showed tumor cells positive for vimentine, protein S100, Melan Aet HMB4, thus confirming the diagnosis of melanoma.

Initially, the excision was incomplete in depth, suggesting a complementary surgery, but the patient refused it and was lost to follow-up, but 3 years later, the patient again consulted after the appearance of an axillary lymphadenopathy and worsening of the skin lesion (Fig. 3). A supplement of tumor removal with lymph node biopsy was performed (Fig. 4). The histological study confirmed the presence of a tumor residue whose resection was incomplete (type R1) with axillary ganglionic metastases. It was decided to peform an amputation of the second ray and the first commissure with cheiroplasty, reconstructing a four-finger hand (Figs. 5 and 6). The reconstruction of the first commissure was done by a simple graft of total skin and not by a flap (Fig. 7).Fig. 3 Clinical aspect of the lesion after 3 years of loss to follow-up

Fig. 4 Tumor removal

Fig. 5 Amputation of the second radius and first commissure with cheiroplasty

Fig. 6 Reconstruction of a four-finger hand

Fig. 7 Reconstruction of the first commissure by total skin graft

A homolateral axillary cleaning was performed at the same time (Fig. 8).Fig. 8 Axillary removal site

The pathological examination of the surgical part showed tumor residue in hypodermis, striated muscle, and metastases in lymph nodes (6N+/25N). The Breslow index was estimated at 11 mm, and the tumor was classified pt4 N3 Mx.

Result

The postoperative result was considered esthetically and functionally satisfying.

Evolution was marked by the appearance of pulmonary metastases, a nodule at the junction of the upper quadrant of the right breast, in view of the left upper iliac spine, and a supraclavicular node. Detogenic adjuvant chemotherapy was introduced with a dose of 250 mg/m2. The patient received three chemotherapy treatments in full. A regression of the nodule under the mammary skin and total disappearance axillary nodes were seen; but the patient’s condition rapidly deteriorated, requiring the cessation of chemotherapy and treatment. The patient died after a 2-month decline.

Discussion

Spitz tumors and nevi were first described in 1948 by Spitz as “juvenile melanomas” [4, 5].

Barnhill et al. [6] classified Spitz tumors into three categories: tumor of Spitz without atypia (classical Spitz nevus), atypical Spitz tumor, and spitzoid malignant melanoma (SMM). However, in a panel study of 10 pathologists who examined 30 Spitz tumors (including Spitz tumors without or with atypia and spitzoid melanomas), no consensus could be reached on the morphological criteria distinguishing between different types of Spitz tumors [7].

Fewer than 30 spitzoid melanoma observations have been reported in the literature. Spitzoid melanoma is therefore rare; its localization in the finger is exceptional and often poses a diagnostic problem. Spitzoid melanoma can occur in children, but is most common in adults [8–10]. Clinically, spitzoid melanomas are nodular lesions that vary over time, often reaching 1 cm or diameter. The nodules are generally amelanotic. They can look like hemangiomas, pyogenic granulomas, xanthogranulomas, or basal cell carcinomas. Less often, lesions are pigmented and have irregular and variable color. Nodular lesions may be crusty and ulcerated.

In our observation, the lesion was unusual on the one hand by its localization at the finger, and on the other hand by its clinical presentation; in effect, the occurrence of the lesion in a young man and its presentation in the form of an unpigmented infiltrated ulceration did not make suspect a melanoma; the first diagnoses mentioned were sarcoma or lymphoma, but histological examination ruled out these two diagnoses on the morphology of the tumor and confirmed the melanic nature of the lesion due to immunolabeling by PS100, Melan A, and HMB 45.

The main problem of histological differential diagnosis is the challenge in distinguishing between spitzoid melanoma and Spitz nevus [3], especially in young patients. Indeed, spitzoid melanoma is exceptional in young people, therefore, many arguments are required to make this diagnosis.

Histopathological features useful for distinguishing the spitzoid melanoma of a Spitz nevus have been reported by several authors, and are represented by the asymmetry of the lesion, ulceration, irregularity of limits, reaching the junction dermoeepidermal, gradual decrease in maturation of melanocytes, increased cell density, and a high mitotic index [11–13]; in our case, the ulcerating and especially infiltrating character of the tumor proliferation was evident from the first biopsy, which allowed for retaining the diagnosis of melanoma.

However, in most cases, these features do not allow for distinction between spitzoid melanoma and Spitz nevus, and recently there have been studies that attempt to use molecular cytogenetics for said distinction. Bastian et al. [14, 15] demonstrated that 80% of the Spitz with an 11p chromosome have an increased number of copies of an allele HRAS oncogenic; this HRAS allele is rarely mutated into malignant melanoma [3, 14, 15]. Stratification of the risk of the atypical spitzoid melanocytic proliferation was recently addressed with the use of a new test in situ four-probe fluorescence (FISH) hybridization for 6p25 (RREB1), 11q13 (CCND1), 9p21 (CDKN2a), and 8q24 (MYC) [16] and have identified:Spitzoid melanoma with homozygous 9p21 deletion (high risk).

Spitzoid melanoma with gain of 6p25 and/or 11q13 (medium to high risk).

Atypical Spitz tumor with isolated deletion of 6q23 (risk weak).

Atypical Spitz tumor without FISH abnormality (low to very high risk weak).

In studies using immunohistochemistry, the proliferation index of Ki-67/MIB-1 was suggested as a useful marker to distinguish nevi from melanoma Spitz [17]. In our case, the tumor cells were positive for vimentine, protein S100, and Mélan Aet HMB45 in the immunohistochemical study.

During histological diagnosis of melanoma, the anatomopathological study of the entire tumor allows for the measurement of the thickness, thus establishing the Breslow index, the main prognostic criterion [18]. However, surgical recovery will often be necessary depending on this histological analysis.

Other major prognostic criteria are provided by the anatomopathological study of the primary tumor with Clark level [19] and the presence or absence of an ulcer, which was the case for our observation.

Finally, this histological study will establish the local stage of melanoma according to the American Joint Committee on Cancer (AJCC) Melanoma Committee classification [20].

Melanoma of the finger has a poor prognosis compared with other localizations of melanoma. Although it is accessible and discovered early, melanoma of the finger is often considered clinically as a benign lesion, delaying diagnosis and treatment [21]. Average follow-up of melanoma of the finger depends closely on the delay of diagnosis after the appearance of the tumor as well as the anatomical site of the tumor. The subungual melanoma has a poorer prognosis than other melanomas of the finger due to its more aggressive behavior and its fast metastatic dissemination. The 5-year survival is estimated at 37% for ungual localization, and 75% in outside the subungual location [21]. Local recurrence of melanoma is a strong marker of aggressiveness. Survival in case of metastasis distance is 6–8 months [22].

In our observation, the tumor was located at the index distance from the subungual region, however, evolution was rapidly metastatic due to delayed diagnosis.

Management of patients with histopathological diagnosis of a spitzoid melanoma should be decided with a multidisciplinary and informed-consent approach. It follows the same treatment as other types of melanoma, and depends on tumor thickness, Breslow classification, and Clark level.

The opportunity for sentinel node biopsy for melanoma has to be assessed on a case-by-case basis. The decision must be made, whereas in the melanomas of Spitz, the presence of tumor cells isolated in the sentinel node is not a sign of equivocal malignancy [23, 24] and is not an indication of complementary lymphadenectomy, due to ambiguity of the primary syndrome. In our observation, biopsy of an axillary node was done and histological study confirmed lymph node metastasis, leading to a subsequent removal during amputation of the second ray.

For melanoma in situ, excision must have a margin of 0.5 cm of healthy skin. For invasive melanomas less than 1 mm thick, the sound margin must be 1 cm; for 1–2 mm the thickness of the margin is 1–2 cm, and for melanoma 2–4 mm thick, the recommended margin is 2 cm [25–27]. Amputation is still possible and must be done at distance of the lesion when that is circumferential. Although radical amputations are to be avoided even in cases of multiple lesions, they can prove to be the most carcinological surgery, with reassuring results. They are a necessity when the margins of an excision always keep tumor residue, which is the case with delayed diagnosis and therapy.

In our case, an amputation of the second ray was carried out due to the very invasive character of the tumor. We were led to make a cheiroplasty [28, 29] of the hand since the index finger is the most used finger after the thumb. This is an essential element of the pollicidigitale socket and a stabilization in the global digitopalmar grip [30].

Cheiroplasty is called recovery plastie by Tubiana. It may be considered to cover a loss of substance from the hand or a finger. In our clinical case it covered more than half of the loss of dorsal substance. The remaining part was covered by a total skin instead of an associated posterior interbone flap generally done with cheiroplasty [31], given the difficulty of dissection, risk of necrosis, and invasive technique in a field with a metastatic tumor, with a precarious general condition.

Conclusion

Spitzoid melanoma is exceptional, posing difficulties in diagnostics, mainly with the Spitz nevus.

Knowledge of this rare form of melanoma, with its unusual morphology, is important to avoid misdiagnosis as well as delays in diagnosis and subsequent therapy.

Histological and immunohistochemical studies contribute to the diagnostic confirmation of spitzoid melanoma. Suspect criteria in this entity are large asymmetric lesion, high cell density clone, epithelioid or atypical cytology, multiple and deep mitosis, and focal rate of proliferation. In front of a spitzoid histological aspect of a lesion in a young subject, it is important not to underestimate a spitzoid melanoma, which may involve the vital prognosis in case of delayed diagnosis or therapy.

Acknowledgements

Not applicable.

Author contributions

All authors were involved in writing, reading, and editing the manuscript. All authors read and approved the final manuscript.

Funding

No funding was received for this study.

Data availability

Data supporting the findings of this study are available from the corresponding author upon reasonable request.

Declarations

Ethics approval and consent to participate

Ethical approval is not required at our institution to publish an anonymous case report.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Koh HK Cutaneous melanoma N Engl J Med 1991 325 3 171 182 10.1056/NEJM199107183250306 1805813
Koh HK. Cutaneous melanoma. N Engl J Med. 1991;325(3):171–82.1805813 10.1056/NEJM199107183250306
2. Warso M Gray T Gonzalez M Melanoma of the hand J Hand Surg 1997 2 354 360 10.1016/S0363-5023(97)80178-5
Warso M, Gray T, Gonzalez M. Melanoma of the hand. J Hand Surg. 1997;2:354–60.10.1016/S0363-5023(97)80178-5
3. Kamino H Spitzoid melanoma Clin Dermatol 2009 27 6 545 555 10.1016/j.clindermatol.2008.09.013 19880042
Kamino H. Spitzoid melanoma. Clin Dermatol. 2009;27(6):545–55.19880042 10.1016/j.clindermatol.2008.09.013
4. Spitz S Melanomas of childhood Am J Pathol 1948 24 3 591 609 18859360
Spitz S. Melanomas of childhood. Am J Pathol. 1948;24(3):591–609.18859360
5. Allen AC Spitz S Malignant melanoma; a clinicopathological analysis of the criteria for diagnostic et pronostic Cancer 1953 6 1 1 45 10.1002/1097-0142(195301)6:1<1::AID-CNCR2820060102>3.0.CO;2-C 13009650
Allen AC, Spitz S. Malignant melanoma; a clinicopathological analysis of the criteria for diagnostic et pronostic. Cancer. 1953;6(1):1–45.13009650 10.1002/1097-0142(195301)6:1<1::AID-CNCR2820060102>3.0.CO;2-C
6. Barnhill RL The Spitzoid lesion : rethinking Spitz tumors, atypical variants, ‘Spitzoid melanoma' and risk assessmen Modern Pathol 2006 19 2 S21 33 10.1038/modpathol.3800519
Barnhill RL. The Spitzoid lesion : rethinking Spitz tumors, atypical variants, ‘Spitzoid melanoma’ and risk assessmen. Modern Pathol. 2006;19(2):S21-33.10.1038/modpathol.3800519
7. Barnhill RL Argenyi ZB From L Glass LF Maize JC Mihm MC Atypical Spitz naevus/tumeurs : absence de consensus pour le diagnostic, discrimination par mélanome, et prédiction des résultats Hum Pathol 1999 30 5 513 520 10.1016/S0046-8177(99)90193-4 10333219
Barnhill RL, Argenyi ZB, From L, Glass LF, Maize JC, Mihm MC, et al. Atypical Spitz naevus/tumeurs : absence de consensus pour le diagnostic, discrimination par mélanome, et prédiction des résultats. Hum Pathol. 1999;30(5):513–20.10333219 10.1016/S0046-8177(99)90193-4
8. Keyhani A Comparaison du comportement clinique du mélanome des mains et des pieds Une étude Cancer 1977 40 6 3168 3173
Keyhani A. Comparaison du comportement clinique du mélanome des mains et des pieds. Une étude Cancer. 1977;40(6):3168–73.
9. Kato T Suetake T Sugiyama Y Tanita Y Kumasaka K Takematsu H Improvement taux de survie des patients atteints d’un mélanome acral observé au cours des 22 dernières années à Sendai Japon. Clin Exp Dermatol 1993 18 2 107 110 10.1111/j.1365-2230.1993.tb00988.x
Kato T, Suetake T, Sugiyama Y, Tanita Y, Kumasaka K, Takematsu H, et al. Improvement taux de survie des patients atteints d’un mélanome acral observé au cours des 22 dernières années à Sendai. Japon Clin Exp Dermatol. 1993;18(2):107–10.10.1111/j.1365-2230.1993.tb00988.x
10. Sagebiel RW Banda PW Schneider JS Crutcher WA Age distribution and histologic patterns of dysplastic nevi J Am Acad Dermatol 1985 13 6 975 982 10.1016/S0190-9622(85)70248-4 4078104
Sagebiel RW, Banda PW, Schneider JS, Crutcher WA. Age distribution and histologic patterns of dysplastic nevi. J Am Acad Dermatol. 1985;13(6):975–82.4078104 10.1016/S0190-9622(85)70248-4
11 Goh EH Zarina AL Thambidorai CR Maizaton AA Siti AMA Somasundram S Amelanotic spitzoid melanoma in a prepubescent boy Pediatr Surg Int 2008 4 447 449 10.1007/s00383-007-1923-9
Goh EH, Zarina AL, Thambidorai CR, Maizaton AA, Siti AMA, Somasundram S. Amelanotic spitzoid melanoma in a prepubescent boy. Pediatr Surg Int. 2008;4:447–9.10.1007/s00383-007-1923-9
12. Fabrizi G Massi G Spitzoid malignant melanoma in teenagers : an entity with no better pronostic supérieur à celui d’autres formes de mélanome Histopathology 2001 38 5 448 453 10.1046/j.1365-2559.2001.01102.x 11422482
Fabrizi G, Massi G. Spitzoid malignant melanoma in teenagers : an entity with no better pronostic supérieur à celui d’autres formes de mélanome. Histopathology. 2001;38(5):448–53.11422482 10.1046/j.1365-2559.2001.01102.x
13 Quinn MJ Thompson JE Crotty K McCarthy WH Coates AS Subungual melanoma of J Hand Surg 1996 21 3 506 5011 10.1016/S0363-5023(96)80371-6
Quinn MJ, Thompson JE, Crotty K, McCarthy WH, Coates AS. Subungual melanoma of. J Hand Surg. 1996;21(3):506–5011.10.1016/S0363-5023(96)80371-6
14. Bastian BC Wesselmann U Pinkel D Leboit PE Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma J Invest Dermatol 1999 113 6 1065 1069 10.1046/j.1523-1747.1999.00787.x 10594753
Bastian BC, Wesselmann U, Pinkel D, Leboit PE. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol. 1999;113(6):1065–9.10594753 10.1046/j.1523-1747.1999.00787.x
15. Bastian BC LeBoit PE Pinkel D Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features Am J Pathol 2000 157 3 967 972 10.1016/S0002-9440(10)64609-3 10980135
Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000;157(3):967–72.10980135 10.1016/S0002-9440(10)64609-3
16. Gerami P Scolyer RA Xu X Elder DE Abraham RM Fullen D Risk assessment for néoplasmes mélanocytaires atypiques spitzoïdes utilisant FISH pour identifier la copie chromosomique Am J Surg Pathol 2013 37 5 676 684 10.1097/PAS.0b013e3182753de6 23388126
Gerami P, Scolyer RA, Xu X, Elder DE, Abraham RM, Fullen D, et al. Risk assessment for néoplasmes mélanocytaires atypiques spitzoïdes utilisant FISH pour identifier la copie chromosomique. Am J Surg Pathol. 2013;37(5):676–84.23388126 10.1097/PAS.0b013e3182753de6
17. Bergman R Malkin L Sabo E Kerner H MIB-1, anticorps monoclonal, pour déterminer activité proliférative de l’antigène Ki-67 en complément du différentiel histopathologique diagnostic de Spitz nevi J Am Acad Dermatol 2001 44 3 500 504 10.1067/mjd.2001.111635 11209122
Bergman R, Malkin L, Sabo E, Kerner H. MIB-1, anticorps monoclonal, pour déterminer activité proliférative de l’antigène Ki-67 en complément du différentiel histopathologique diagnostic de Spitz nevi. J Am Acad Dermatol. 2001;44(3):500–4.11209122 10.1067/mjd.2001.111635
18. Kopf AW Gross DF Rogers GS Rigel DS Hellman LJ Levenstein M Prognostic index for malignant melanoma Cancer 1987 59 6 1236 1241 10.1002/1097-0142(19870315)59:6<1236::AID-CNCR2820590634>3.0.CO;2-I 3815299
Kopf AW, Gross DF, Rogers GS, Rigel DS, Hellman LJ, Levenstein M, et al. Prognostic index for malignant melanoma. Cancer. 1987;59(6):1236–41.3815299 10.1002/1097-0142(19870315)59:6<1236::AID-CNCR2820590634>3.0.CO;2-I
19. Wanebo HJ Fortner JG Woodruff J MacLean B Binkowski E Selection of the optimum traitement chirurgical du mélanome de stade I par profondeur de microinvasion : utilisation de la Clark-Breslow Ann Surg 1975 182 3 302 315 10.1097/00000658-197509000-00013 1164058
Wanebo HJ, Fortner JG, Woodruff J, MacLean B, Binkowski E. Selection of the optimum traitement chirurgical du mélanome de stade I par profondeur de microinvasion : utilisation de la Clark-Breslow. Ann Surg. 1975;182(3):302–15.1164058 10.1097/00000658-197509000-00013
20. Gershenwald JE Scolyer RA Hess KR Sondak VK Long GV Ross MI Melanoma mise en scène: changements fondés sur des données probantes au sein du comité mixte américain sur le cancerCA Cancer J Clin 2017 67 6 472 492
Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, et al. Melanoma mise en scène: changements fondés sur des données probantes au sein du comité mixte américain sur le cancerCA Cancer. J Clin. 2017;67(6):472–92.
21. Hove LM Akslen LA Clinicopathological characteristics of melanomas of the hand J Hand Surg 1999 24 4 460 464 10.1054/JHSB.1999.0155
Hove LM, Akslen LA. Clinicopathological characteristics of melanomas of the hand. J Hand Surg. 1999;24(4):460–4.10.1054/JHSB.1999.0155
22 Boukredera M Benhabiles A Mélanome malin unguéal du pouce traité par exérèse et interférant alpha—survie à 10 ans à propos d’un cas Hand Surg Rehabil 2017 36 6 471 472 10.1016/j.hansur.2017.10.133
Boukredera M, Benhabiles A. Mélanome malin unguéal du pouce traité par exérèse et interférant alpha—survie à 10 ans à propos d’un cas. Hand Surg Rehabil. 2017;36(6):471–2.10.1016/j.hansur.2017.10.133
23 LeBoit PE What do these cells prove? Am J Dermatopathol 2003 25 4 355 356 10.1097/00000372-200308000-00015 12876498
LeBoit PE. What do these cells prove? Am J Dermatopathol. 2003;25(4):355–6.12876498 10.1097/00000372-200308000-00015
24. Ferrara G, Errico ME, Donofrio V, Zalaudek I, Argenziano G. Melanocytic tumors of potentiel malin incertain dans l’enfance : avons-nous vraiment besoin
25. .
26. Balch CM Urist MM Karakousis CP Smith TJ Temple WJ Drzewiecki K Efficacy of surgical margins of 2 cm for melanoma of average thickness (1 to 4 mm) results of a multi-institutional randomized surgical trial Ann Surg 1993 218 3 262 269 10.1097/00000658-199309000-00005 8373269
Balch CM, Urist MM, Karakousis CP, Smith TJ, Temple WJ, Drzewiecki K, et al. Efficacy of surgical margins of 2 cm for melanoma of average thickness (1 to 4 mm) results of a multi-institutional randomized surgical trial. Ann Surg. 1993;218(3):262–9.8373269 10.1097/00000658-199309000-00005
27 Veronesi U Cascinelli N Adamus J Balch C Bandiera D Barchuk A Thin stage I primary cutaneous malignant melanoma. comparison of excision with margins of 1 or 3 cm N Engl J Med. 1988 318 18 1159 1162 10.1056/NEJM198805053181804
Veronesi U, Cascinelli N, Adamus J, Balch C, Bandiera D, Barchuk A, et al. Thin stage I primary cutaneous malignant melanoma. comparison of excision with margins of 1 or 3 cm N. Engl J Med. 1988;318(18):1159–62.10.1056/NEJM198805053181804
28 Schonauer F Schaden D Teo TC excision Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 1999 25 4 424 426
Schonauer F, Schaden D, Teo TC. excision. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 1999;25(4):424–6.
29. Küntscher MV Erdmann D Homann HH Steinau HU Levin SL Germann G The concept Net flaps: classification, indications and analysis of their clinical value Plast Reconstr Surg 2001 108 4 885 896 10.1097/00006534-200109150-00011 11547143
Küntscher MV, Erdmann D, Homann HH, Steinau HU, Levin SL, Germann G. The concept Net flaps: classification, indications and analysis of their clinical value. Plast Reconstr Surg. 2001;108(4):885–96.11547143 10.1097/00006534-200109150-00011
30. Littler JW Architectural principles of reconstructive hand surgery Plast Reconstr Surg 1951 8 4 331 10.1097/00006534-195110000-00025
Littler JW. Architectural principles of reconstructive hand surgery. Plast Reconstr Surg. 1951;8(4):331.10.1097/00006534-195110000-00025
31. De Cheveigné C Croutzet P Ferreira B Gaston-Nouvel A door» by association of a cheiroplasty and a posterior interosseous flap, to comments on 3 cases Chir Main 2014 33 6 416
De Cheveigné C, Croutzet P, Ferreira B, Gaston-Nouvel A. door» by association of a cheiroplasty and a posterior interosseous flap, to comments on 3 cases. Chir Main. 2014;33(6):416.
